These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 18835764)
21. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519 [TBL] [Abstract][Full Text] [Related]
22. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery. Xu W; Wei X; Wei K; Cao X; Zhong S Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077 [TBL] [Abstract][Full Text] [Related]
23. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. Fischer S; Schlosser E; Mueller M; Csaba N; Merkle HP; Groettrup M; Gander B J Drug Target; 2009 Sep; 17(8):652-61. PubMed ID: 19622019 [TBL] [Abstract][Full Text] [Related]
24. Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting. Diab R; Brillault J; Bardy A; Gontijo AV; Olivier JC Int J Pharm; 2012 Oct; 436(1-2):833-9. PubMed ID: 22846409 [TBL] [Abstract][Full Text] [Related]
25. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361 [TBL] [Abstract][Full Text] [Related]
26. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs. Joung YK; Choi JH; Park KM; Park KD Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485 [TBL] [Abstract][Full Text] [Related]
27. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Krishnamachari Y; Madan P; Lin S Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982 [TBL] [Abstract][Full Text] [Related]
28. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575 [TBL] [Abstract][Full Text] [Related]
29. PLGA/chitosan composites from a combination of spray drying and supercritical fluid foaming techniques: new carriers for DNA delivery. Nie H; Lee LY; Tong H; Wang CH J Control Release; 2008 Aug; 129(3):207-14. PubMed ID: 18539352 [TBL] [Abstract][Full Text] [Related]
30. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558 [TBL] [Abstract][Full Text] [Related]
31. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614 [TBL] [Abstract][Full Text] [Related]
32. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release. Park W; Na K Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. Zolnik BS; Burgess DJ J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629 [TBL] [Abstract][Full Text] [Related]
34. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729 [TBL] [Abstract][Full Text] [Related]
35. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
36. Protective immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolic acid) microspheres. Zhao H; Wu B; Wu H; Su L; Pang J; Yang T; Liu Y Biotechnol Lett; 2006 Aug; 28(16):1299-304. PubMed ID: 16804764 [TBL] [Abstract][Full Text] [Related]
37. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
38. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. Fischer S; Foerg C; Ellenberger S; Merkle HP; Gander B J Control Release; 2006 Mar; 111(1-2):135-44. PubMed ID: 16377017 [TBL] [Abstract][Full Text] [Related]
39. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres. Gajendiran M; Divakar S; Raaman N; Balasubramanian S Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139 [TBL] [Abstract][Full Text] [Related]
40. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology. San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]